These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8438462)

  • 21. Pulse therapy for rejection with deoxyspergualin in renal recipients: a multicenter controlled study.
    Amemiya H; Ota K; Sonoda T; Fukao K; Taguchi Y; Isono K; Omoto R; Takagi H; Oka T; Orita K
    Transplant Proc; 1992 Aug; 24(4):1375-6. PubMed ID: 1496591
    [No Abstract]   [Full Text] [Related]  

  • 22. 15-Deoxyspergualin after cardiac and renal allotransplantation in primates.
    Reichenspurner H; Hildebrandt A; Human PA; Boehm DH; Rose AG; Schorlemmer HU; Reichart B
    Transplant Proc; 1990 Aug; 22(4):1618-9. PubMed ID: 2389423
    [No Abstract]   [Full Text] [Related]  

  • 23. Pilot evaluation of 15-deoxyspergualin for refractory acute renal transplant rejection.
    Matas AJ; Gores PF; Kelley SL; Bielefield-Skrokov M; Kinaszczuk M; Gruessner RW; Najarian JS
    Clin Transplant; 1994 Apr; 8(2 Pt 1):116-9. PubMed ID: 8019020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H
    Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract]   [Full Text] [Related]  

  • 25. A novel rescue drug, 15-deoxyspergualin. First clinical trials for recurrent graft rejection in renal recipients.
    Amemiya H; Suzuki S; Ota K; Takahashi K; Sonoda T; Ishibashi M; Omoto R; Koyama I; Dohi K; Fukuda Y
    Transplantation; 1990 Feb; 49(2):337-43. PubMed ID: 2407004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a novel immunosuppressive agent, deoxyspergualin, in a case of ABO-incompatible kidney transplantation.
    Takahasi K; Ota K; Ooba S; Tanabe K; Fuchinoue S; Honda H; Teraoka S; Toma H; Agishi T; Amemiya H
    Clin Transpl; 1989; ():306-7. PubMed ID: 2487584
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cyclosporin in transplantation management--especially after kidney transplantation].
    Quellhorst E
    Internist (Berl); 1996 Jan; 37(1):88-90. PubMed ID: 8837834
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic effect of 15-deoxyspergualin on acute graft rejection in canine liver transplantation.
    Kido K; Suzuki S; Amemiya H; Nakano H
    Transpl Int; 1994; 7 Suppl 1():S194-8. PubMed ID: 11271201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 15-Deoxyspergualin and primate heart transplantation.
    Kapelanski DP; Perelman MJ; Faber LA; Paez DE; Rose EF; Behrendt DM
    J Heart Transplant; 1990; 9(6):668-73; discussion 673-4. PubMed ID: 2277306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic use of deoxyspergualin in living related renal transplantation.
    Okazaki H; Sato T; Jimbo M; Senga S; Amada N; Oguma S
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1094-5. PubMed ID: 1989157
    [No Abstract]   [Full Text] [Related]  

  • 31. [Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations].
    Arns W; Budde K; Eitner F; Gwinner W; Hugo C; Pressmar K; Weimann A; Witzke O
    Dtsch Med Wochenschr; 2011 Dec; 136(49):2554-9. PubMed ID: 22131077
    [No Abstract]   [Full Text] [Related]  

  • 32. Gusperimus: immunological mechanism and clinical applications.
    Perenyei M; Jayne DR; Floßmann O
    Rheumatology (Oxford); 2014 Oct; 53(10):1732-41. PubMed ID: 24501242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Intermittent administration of 15-deoxyspergualin for acute on chronic rejection after renal transplantation].
    Kawamoto S; Kanematsu E; Kanimoto Y; Kawada Y
    Hinyokika Kiyo; 1996 Dec; 42(12):931-5. PubMed ID: 9013227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of rejection with deoxyspergualin after renal transplantation].
    Shinohara Y; Imanishi M; Nishioka T; Uemura T; Kanda H; Matsuura T; Akiyama T; Kurita T
    Nihon Hinyokika Gakkai Zasshi; 1992 Feb; 83(2):236-42. PubMed ID: 1556844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunosuppressive effect of deoxyspergualin on acute renal allograft rejection in dogs.
    Fukao K; Otsuka M; Iwasaki H; Yuzawa K; Iwasaki Y
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1090-3. PubMed ID: 2650068
    [No Abstract]   [Full Text] [Related]  

  • 36. Deoxyspergualin: clinical trials in renal graft rejection. Japan Collaborative Transplant Study of Deoxyspergualin.
    Amemiya H
    Ann N Y Acad Sci; 1993 Jun; 685():196-201. PubMed ID: 8363223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of accelerated vascular rejection in a highly immunised renal transplant recipient with immunoadsorption and 15-deoxyspergualin.
    Braun N; Wernet D; Schnaidt M; Bevan DJ; Viebahn R; Risler T
    Transpl Int; 2004 Aug; 17(7):384-6. PubMed ID: 15278264
    [No Abstract]   [Full Text] [Related]  

  • 38. Long-term outcome of cadaveric kidney grafts with triple drug therapy.
    Amemiya H; Suzuki S; Hayashi R; Nakatani T
    Transplant Proc; 1994 Aug; 26(4):2097-8. PubMed ID: 8066683
    [No Abstract]   [Full Text] [Related]  

  • 39. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 40. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis.
    Kliem V; Eberhard OK; Oldhafer K; Schlitt HJ; Behrend M; Schaumann D; Pichlmayr R; Koch KM; Brunkhorst R
    Transplant Proc; 1996 Dec; 28(6):3166-8. PubMed ID: 8962227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.